publication date: Nov. 9, 2018

An Appreciation

Arti Hurria, geriatric oncologist at City of Hope, dies in traffic accident

By Michael Easterling

Communications Department, City of Hope

Arti Hurria, a pioneer of geriatric cancer care at City of Hope, died Nov. 7 in a traffic accident. She was 48.

Hurria was the George Tsai Family Chair in Geriatric Oncology, director of the Center on Cancer and Aging, co-lead of the Cancer Control and Population Sciences Program, vice provost of clinical faculty, a professor in the Department of Medical Oncology & Therapeutics Research, and a medical oncologist at City of Hope.

“Arti Hurria was special,” said Robert Stone, president and CEO of City of Hope. “She was a visionary, a groundbreaking innovator, and the kind of doctor who earned the trust of her patients with her humanity and her compassion. We were incredibly fortunate to know her, to work with her, and to learn from her for more than a decade and we will sorely miss her.”

“It’s hard to believe she is gone. We are overwhelmed with grief,” said Steven Rosen, City of Hope’s provost and chief scientific officer, the Irell & Manella Cancer Center Director’s Distinguished Chair, and the Morgan & Helen Chu Director’s Chair of the Beckman Research Institute. “Our world changed in a moment. Arti represented the best in oncology and humanity.”

Hurria made important contributions to the field of oncology and to the American Society of Clinical Oncology, said ASCO CEO Clifford Hudis.

“Dr. Hurria was a vibrant, shining light in the field of geriatric oncology, and it is impossible to overstate the profound impact she has had on improving … Continue reading Arti Hurria, geriatric oncologist at City of Hope, dies in traffic accident

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2018 The Cancer Letter Inc.